scholarly article | Q13442814 |
P2093 | author name string | Jian Liu | |
Sherket Peterson | |||
P2860 | cites work | Release of cell surface‐associated basic fibroblast growth factor by glycosylphosphatidylinositol‐specific phospholipase C | Q42820716 |
How APC/C orders destruction | Q45345064 | ||
Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence | Q24306149 | ||
Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues | Q28141121 | ||
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate | Q28236334 | ||
Substrate specificity of heparanases from human hepatoma and platelets | Q28276774 | ||
Heparanase in glomerular diseases | Q28303555 | ||
Functions of cell surface heparan sulfate proteoglycans | Q29618521 | ||
Chemoenzymatic Design of Heparan Sulfate Oligosaccharides* | Q33668533 | ||
Unraveling the specificity of heparanase utilizing synthetic substrates | Q33824982 | ||
Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains. | Q33897755 | ||
Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans | Q34083497 | ||
Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins | Q34228210 | ||
Heparan sulfate: growth control with a restricted sequence menu | Q34328757 | ||
Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis | Q34398151 | ||
Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice | Q34876266 | ||
Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes | Q35640553 | ||
Interactions between heparan sulfate and proteins: the concept of specificity | Q36552851 | ||
Heparanase: one molecule with multiple functions in cancer progression | Q37228578 | ||
Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? | Q37407186 | ||
Design of biologically active heparan sulfate and heparin using an enzyme-based approach | Q37456178 | ||
Molecular model of human heparanase with proposed binding mode of a heparan sulfate oligosaccharide and catalytic amino acids | Q38333202 | ||
Mechanism of activation of human heparanase investigated by protein engineering. | Q42045538 | ||
P433 | issue | 41 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | oligosaccharide | Q320607 |
P304 | page(s) | 34836-34843 | |
P577 | publication date | 2012-08-14 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Deciphering mode of action of heparanase using structurally defined oligosaccharides | |
P478 | volume | 287 |
Q34634250 | A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase |
Q36771403 | Analysis of Total Human Urinary Glycosaminoglycan Disaccharides by Liquid Chromatography-Tandem Mass Spectrometry |
Q90404382 | Characterization of Glycosaminoglycans in Gaping and Intact Connective Tissues of Farmed Atlantic Salmon (Salmo salar) Fillets by Mass Spectrometry |
Q27005958 | Chemoenzymatic synthesis of heparan sulfate and heparin |
Q38302345 | Discovery of a heparan sulfate 3-O-sulfation specific peeling reaction |
Q47197453 | Evidence of glucuronidation of the glycation product LW-1: tentative structure and implications for the long-term complications of diabetes |
Q37161285 | Glycan-based biomarkers for mucopolysaccharidoses |
Q51742740 | Glycosaminoglycans affect heparanase location in CHO cell lines. |
Q47897300 | Glycosidase Inhibition by Multivalent Presentation of Heparan Sulfate Saccharides on Bottlebrush Polymers. |
Q38116039 | Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses |
Q37413886 | Heparanase and autoimmune diabetes. |
Q91762127 | Heparanase as an Additional Tool for Detecting Structural Peculiarities of Heparin Oligosaccharides |
Q36797594 | Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway |
Q91087998 | Heparanase-1 activity and the early postnatal prostate development |
Q92073912 | Heparanase: A Challenging Cancer Drug Target |
Q42587945 | Heparanase: From basic research to therapeutic applications in cancer and inflammation |
Q27025052 | Involvement of heparanase in atherosclerosis and other vessel wall pathologies |
Q90680589 | Modulating Heparanase Activity: Tuning Sulfation Pattern and Glycosidic Linkage of Oligosaccharides |
Q33676686 | Molecular mechanism of substrate specificity for heparan sulfate 2-O-sulfotransferase |
Q35953176 | Role of Deacetylase Activity of N-Deacetylase/N-Sulfotransferase 1 in Forming N-Sulfated Domain in Heparan Sulfate |
Q34501966 | Structural characterization of human heparanase reveals insights into substrate recognition. |
Q59807297 | The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard |
Q38238094 | The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics |
Q36744482 | Uncovering the Catalytic Direction of Chondroitin AC Exolyase: FROM THE REDUCING END TOWARDS THE NON-REDUCING END |